Which of the following beta blockers is NOT listed as beta 1 selective?

Nadolol is considered a non-selective beta-blocker, which means it blocks both beta-1 and beta-2 adrenergic receptors. In contrast, the other options listed—Betaxolol, Atenolol, and Esmolol—are all selective for the beta-1 receptors, primarily affecting the heart and helping to manage conditions like hypertension and heart failure without impacting the respiratory system as much as non-selective agents do.

In clinical practice, beta-1 selective blockers are preferred in certain populations, such as patients with asthma or chronic obstructive pulmonary disease, to minimize the risk of bronchoconstriction that can occur with non-selective blockers like Nadolol. Understanding this distinction is crucial for ensuring the safe and effective use of beta-blocker therapy in various patient populations.